Schering’s Vicriviroc R&D To Focus On Treatment-Experienced HIV Patients
This article was originally published in The Pink Sheet Daily
Executive Summary
The decision to focus registration on treatment-experienced patients follows the recent termination of a Phase II trial in treatment-naïve HIV patients.